Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Drug Resistance

  Free Subscription


Articles published in PLoS Med

Retrieve available abstracts of 18 articles:
HTML format



Single Articles


    December 2020
  1. HAUSER A, Kusejko K, Johnson LF, Gunthard HF, et al
    Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study.
    PLoS Med. 2020;17:e1003397.
    PubMed     Abstract available


  2. CILLONI L, Kranzer K, Stagg HR, Arinaminpathy N, et al
    Trade-offs between cost and accuracy in active case finding for tuberculosis: A dynamic modelling analysis.
    PLoS Med. 2020;17:e1003456.
    PubMed     Abstract available


    August 2020
  3. HAGEDOORN NN, Borensztajn DM, Nijman R, Balode A, et al
    Variation in antibiotic prescription rates in febrile children presenting to emergency departments across Europe (MOFICHE): A multicentre observational study.
    PLoS Med. 2020;17:e1003208.
    PubMed     Abstract available


    June 2019
  4. ROGERS VAN KATWYK S, Grimshaw JM, Nkangu M, Nagi R, et al
    Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map.
    PLoS Med. 2019;16:e1002819.
    PubMed     Abstract available


  5. HERNANDEZ-SANTIAGO V, Davey PG, Nathwani D, Marwick CA, et al
    Changes in resistance among coliform bacteraemia associated with a primary care antimicrobial stewardship intervention: A population-based interrupted time series study.
    PLoS Med. 2019;16:e1002825.
    PubMed     Abstract available


    April 2019
  6. COLMAN RE, Mace A, Seifert M, Hetzel J, et al
    Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation.
    PLoS Med. 2019;16:e1002794.
    PubMed     Abstract available


  7. STRYDOM N, Gupta SV, Fox WS, Via LE, et al
    Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization.
    PLoS Med. 2019;16:e1002773.
    PubMed     Abstract available


    March 2019
  8. MCLEOD M, Ahmad R, Shebl NA, Micallef C, et al
    A whole-health-economy approach to antimicrobial stewardship: Analysis of current models and future direction.
    PLoS Med. 2019;16:e1002774.
    PubMed     Abstract available


    September 2018
  9. SUTHAR AB, Moonan PK, Alexander HL
    Towards national systems for continuous surveillance of antimicrobial resistance: Lessons from tuberculosis.
    PLoS Med. 2018;15:e1002658.
    PubMed     Abstract available


    March 2018
  10. SCHAR D, Sommanustweechai A, Laxminarayan R, Tangcharoensathien V, et al
    Surveillance of antimicrobial consumption in animal production sectors of low- and middle-income countries: Optimizing use and addressing antimicrobial resistance.
    PLoS Med. 2018;15:e1002521.
    PubMed     Abstract available


  11. STEKLER JD, Milne R, Payant R, Beck I, et al
    Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort.
    PLoS Med. 2018;15:e1002537.
    PubMed     Abstract available


    February 2018
  12. YIN YP, Han Y, Dai XQ, Zheng HP, et al
    Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: A retrospective study of national surveillance data from 2013 to 2016.
    PLoS Med. 2018;15:e1002499.
    PubMed     Abstract available


    November 2017
  13. SZUBERT AJ, Prendergast AJ, Spyer MJ, Musiime V, et al
    Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
    PLoS Med. 2017;14:e1002432.
    PubMed     Abstract available


    October 2017
  14. WHITTLES LK, White PJ, Didelot X
    Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: A modelling study.
    PLoS Med. 2017;14:e1002416.
    PubMed     Abstract available


    August 2017
  15. WERNLI D, Jorgensen PS, Harbarth S, Carroll SP, et al
    Antimicrobial resistance: The complex challenge of measurement to inform policy and the public.
    PLoS Med. 2017;14:e1002378.
    PubMed     Abstract available


    July 2017
  16. WI T, Lahra MM, Ndowa F, Bala M, et al
    Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action.
    PLoS Med. 2017;14:e1002344.
    PubMed     Abstract available


  17. ALIROL E, Wi TE, Bala M, Bazzo ML, et al
    Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.
    PLoS Med. 2017;14:e1002366.
    PubMed     Abstract available


    February 2017
  18. COX H, Dickson-Hall L, Ndjeka N, Van't Hoog A, et al
    Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.
    PLoS Med. 2017;14:e1002238.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: